Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the β-adrenergic system. (Q38293740)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523517%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

review article

1 reference

title

Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the β-adrenergic system (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523517%20AND%20SRC:MED&resulttype=core&format=json

retinopathy of prematurity

25 February 2020

main subject

pathogenesis

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523517%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Giovanni Casini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523517%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

author name string

Massimo Dal Monte

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523517%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Marta Daniotti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523517%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Federica Sereni

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523517%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Paola Bagnoli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523517%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

publication date

19 December 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523517%20AND%20SRC:MED&resulttype=core&format=json

Medicinal Research Reviews

25 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523517%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523517%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

page(s)

619-652

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523517%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523517%20AND%20SRC:MED&resulttype=core&format=json

Propranolol for severe hemangiomas of infancy.

25 February 2020

cites work

1 reference

Propranolol for severe infantile hemangiomas: follow-up report

21 January 2018

1 reference

Vascular endothelial growth factor in eye disease

21 January 2018

1 reference

Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.

21 January 2018

1 reference

Antiangiogenic effects of β2 -adrenergic receptor blockade in a mouse model of oxygen-induced retinopathy.

21 January 2018

1 reference

Beta-adrenoreceptor agonism influences retinal responses to hypoxia in a model of retinopathy of prematurity.

21 January 2018

1 reference

Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives.

21 January 2018

1 reference

Beta3-adrenergic receptors modulate vascular endothelial growth factor release in response to hypoxia through the nitric oxide pathway in mouse retinal explants.

21 January 2018

1 reference

Infantile hemangiomas and retinopathy of prematurity: possible association.

21 January 2018

1 reference

Infantile hemangiomas and retinopathy of prematurity: clues to the regulation of vasculogenesis.

21 January 2018

1 reference

Hypoxia-induced angiogenesis: good and evil

21 January 2018

1 reference

Decreased eNOS protein expression in involuting and propranolol-treated hemangiomas.

21 January 2018

1 reference

β3-adrenergic receptor activity modulates melanoma cell proliferation and survival through nitric oxide signaling

21 January 2018

1 reference

Hypoxia, HIF and the placenta.

21 January 2018

1 reference

Human fetal sympathoadrenal responsiveness

21 January 2018

1 reference

Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics.

21 January 2018

1 reference

Growth characteristics of infantile hemangiomas: implications for management.

21 January 2018

1 reference

21 January 2018

1 reference

Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma

21 January 2018

1 reference

Monoclonal expansion of endothelial cells in hemangioma: an intrinsic defect with extrinsic consequences?

21 January 2018

1 reference

Are infantile hemangiomas of placental origin?

21 January 2018

1 reference

Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma

21 January 2018

1 reference

Ipsilateral hemangioma and aortic arch anomalies in posterior fossa malformations, hemangiomas, arterial anomalies, coarctation of the aorta, and cardiac defects and eye abnormalities (PHACE) anomaly: report and review

21 January 2018

1 reference

Retinal neovascular markers in retinopathy of prematurity: aetiological implications

21 January 2018

1 reference

Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma

21 January 2018

1 reference

VEGF receptor signalling - in control of vascular function

21 January 2018

1 reference

Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1

21 January 2018

1 reference

Increased circulating AC133+ CD34+ endothelial progenitor cells in children with hemangioma

21 January 2018

1 reference

Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease

21 January 2018

1 reference

Propranolol inhibits endothelial progenitor cell homing: a possible treatment mechanism of infantile hemangioma

21 January 2018

1 reference

Hemangiomas - current therapeutic strategies

21 January 2018

1 reference

A meta-analysis on the effectiveness of propranolol for the treatment of infantile airway haemangiomas

21 January 2018

1 reference

Propranolol for the treatment of airway hemangiomas: a case series and treatment algorithm

21 January 2018

1 reference

Propranolol for the treatment of a life-threatening subglottic and mediastinal infantile hemangioma

21 January 2018

1 reference

The use of propranolol in the treatment of periocular infantile haemangiomas: a review

21 January 2018

1 reference

Propranolol for infantile haemangiomas: a review

21 January 2018

1 reference

Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action

21 January 2018

1 reference

Effects of propranolol on the proliferation and apoptosis of hemangioma-derived endothelial cells

21 January 2018

1 reference

Propranolol inhibits growth of hemangioma-initiating cells but does not induce apoptosis

21 January 2018

1 reference

Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1α protein-dependent mechanism

21 January 2018

1 reference

Serum-level changes of vascular endothelial growth factor in children with infantile hemangioma after oral propranolol therapy

21 January 2018

1 reference

Propranolol-mediated attenuation of MMP-9 excretion in infants with hemangiomas.

21 January 2018

1 reference

Propranolol induces regression of hemangioma cells through HIF-1α-mediated inhibition of VEGF-A.

21 January 2018

1 reference

HIF-1alpha links beta-adrenoceptor agonists and pancreatic cancer cells under normoxic condition

21 January 2018

1 reference

The role of β-adrenergic receptor signaling in the proliferation of hemangioma-derived endothelial cells

21 January 2018

1 reference

Tocolysis with the β-2-sympathomimetic hexoprenaline increases occurrence of infantile haemangioma in preterm infants

21 January 2018

1 reference

Propranolol-resistant infantile haemangiomas.

21 January 2018

1 reference

Infantile haemangiomas that failed treatment with propranolol: clinical and histopathological features

21 January 2018

1 reference

Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells

21 January 2018

1 reference

Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability

21 January 2018

1 reference

Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control

21 January 2018

1 reference

Through the eyes of a child: understanding retinopathy through ROP the Friedenwald lecture

21 January 2018

1 reference

Proliferative retinopathies: angiogenesis that blinds

21 January 2018

1 reference

Role of beta-adrenergic receptors in inflammatory marker expression in Müller cells.

21 January 2018

1 reference

Müller cell-derived VEGF is a significant contributor to retinal neovascularization

21 January 2018

1 reference

Respiratory effects of beta-blocker therapy in heart failure.

21 January 2018

1 reference

Beta-adrenergic blockers for chronic heart failure

21 January 2018

1 reference

Beta-2 receptor antagonists for traumatic brain injury: a systematic review of controlled trials in animal models

21 January 2018

1 reference

Regulation of hypoxia-induced release of corticotropin-releasing factor in the rat hypothalamus by norepinephrine

21 January 2018

1 reference

Chronic prenatal hypoxia sensitizes beta-adrenoceptors in the embryonic heart but causes postnatal desensitization

21 January 2018

1 reference

Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491.

21 January 2018

1 reference

VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity

21 January 2018

1 reference

Propranolol concentrations after oral administration in term and preterm neonates.

21 January 2018

1 reference

Pharmacological evidence for the presence of functional beta(3)-adrenoceptors in rat retinal blood vessels.

21 January 2018

1 reference

Beta 3-adrenergic receptors regulate retinal endothelial cell migration and proliferation.

21 January 2018

1 reference

Beta-adrenergic receptor regulation of growth factor protein levels in human choroidal endothelial cells

21 January 2018

1 reference

Beta 3-adrenergic receptors mediate choroidal endothelial cell invasion, proliferation, and cell elongation

21 January 2018

1 reference

Differential expression of pro- and antiangiogenic factors in mouse strain-dependent hypoxia-induced retinal neovascularization

21 January 2018

1 reference

Propranolol inhibition of β-adrenergic receptor does not suppress pathologic neovascularization in oxygen-induced retinopathy

21 January 2018

1 reference

Mediation of most atypical effects by species homologues of the beta 3-adrenoceptor

21 January 2018

1 reference

Comparative pharmacology of human beta-adrenergic receptor subtypes--characterization of stably transfected receptors in CHO cells

21 January 2018

1 reference

Racial variation in retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group.

21 January 2018

1 reference

The β-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseases

21 January 2018

1 reference

Hetero-oligomerization between beta2- and beta3-adrenergic receptors generates a beta-adrenergic signaling unit with distinct functional properties

21 January 2018

1 reference

Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization.

21 January 2018

1 reference

beta3-adrenoceptors in the cardiovascular system: putative roles in human pathologies

21 January 2018

1 reference

The preferential beta3-adrenoceptor agonist BRL 37344 increases force via beta1-/beta2-adrenoceptors and induces endothelial nitric oxide synthase via beta3-adrenoceptors in human atrial myocardium

21 January 2018

1 reference

Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium

21 January 2018

1 reference

Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide

21 January 2018

1 reference

Inducible nitric oxide synthase mediates hypoxia-induced hypoxia-inducible factor-1 alpha activation and vascular endothelial growth factor expression in oxygen-induced retinopathy.

21 January 2018

1 reference

Accumulation of HIF-1alpha under the influence of nitric oxide.

21 January 2018

1 reference

Regulation of HIF-1alpha stability through S-nitrosylation

21 January 2018

1 reference

Relation of endothelial nitric oxide synthase gene to plasma nitric oxide level, endothelial function, and blood pressure in African Americans

21 January 2018

1 reference

Endothelial nitric oxide synthase genotypes in the etiology of retinopathy of prematurity in premature infants.

21 January 2018

1 reference

Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide

21 January 2018

1 reference

Nitric oxide is proangiogenic in the retina and choroid.

21 January 2018

1 reference

Systemic beta-blockers may reduce the need for repeated intravitreal injections in patients with wet age-related macular degeneration treated by bevacizumab

21 January 2018

1 reference

Hypoxia in tumors: pathogenesis-related classification, characterization of hypoxia subtypes, and associated biological and clinical implications

21 January 2018

1 reference

HIFs, angiogenesis, and cancer

21 January 2018

1 reference

Molecular pathways: beta-adrenergic signaling in cancer

21 January 2018

1 reference

Changes in sympathetic nerve activity of the mammalian ovary during a normal estrous cycle and in polycystic ovary syndrome: Studies on norepinephrine release.

21 January 2018

1 reference

Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients

21 January 2018

1 reference

Pancreatic cancer cells and normal pancreatic duct epithelial cells express an autocrine catecholamine loop that is activated by nicotinic acetylcholine receptors α3, α5, and α7.

21 January 2018

1 reference

Nicotine promotes colon tumor growth and angiogenesis through beta-adrenergic activation

21 January 2018

1 reference

Expression of beta2-adrenergic receptor in oral squamous cell carcinoma

21 January 2018

1 reference

Stress hormones increase cell proliferation and regulates interleukin-6 secretion in human oral squamous cell carcinoma cells

21 January 2018

1 reference

Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression

21 January 2018

1 reference

β-adrenoceptors are upregulated in human melanoma and their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell lines

21 January 2018

1 reference

Inhibition of pancreatic cancer cell proliferation by propranolol occurs through apoptosis induction: the study of beta-adrenoceptor antagonist's anticancer effect in pancreatic cancer cell

21 January 2018

1 reference

β2-adrenoceptor blocker synergizes with gemcitabine to inhibit the proliferation of pancreatic cancer cells via apoptosis induction

21 January 2018

1 reference

β2-adrenoceptor blockage induces G1/S phase arrest and apoptosis in pancreatic cancer cells via Ras/Akt/NFκB pathway

21 January 2018

1 reference

New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myeloma

21 January 2018

1 reference

Stress hormone-mediated invasion of ovarian cancer cells

21 January 2018

1 reference

Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells

21 January 2018

1 reference

Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion

21 January 2018

1 reference

Pharmacological targeting of β-adrenergic receptor functions abrogates NF-κB signaling and MMP-9 secretion in medulloblastoma cells

21 January 2018

1 reference

Src activation by β-adrenoreceptors is a key switch for tumour metastasis.

21 January 2018

1 reference

Beta-adrenergic growth regulation of human cancer cell lines derived from pancreatic ductal carcinomas

21 January 2018

1 reference

Mechanisms of smoking-related lung and pancreatic adenocarcinoma development

21 January 2018

1 reference

Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs

21 January 2018

1 reference

Cooperative regulation of non-small cell lung carcinoma by nicotinic and beta-adrenergic receptors: a novel target for intervention

21 January 2018

1 reference

The β2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells

21 January 2018

1 reference

Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma

21 January 2018

1 reference

Surgical stress promotes tumor growth in ovarian carcinoma.

21 January 2018

1 reference

Psychosocial stress augments tumor development through beta-adrenergic activation in mice

21 January 2018

1 reference

Stress hormones promote growth of B16-F10 melanoma metastases: an interleukin 6- and glutathione-dependent mechanism.

21 January 2018

1 reference

Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma

21 January 2018

1 reference

The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers.

21 January 2018

1 reference

The sympathetic nervous system induces a metastatic switch in primary breast cancer

21 January 2018

1 reference

Stimulation of host bone marrow stromal cells by sympathetic nerves promotes breast cancer bone metastasis in mice

21 January 2018

1 reference

Beta-adrenergic modulation of NNK-induced lung carcinogenesis in hamsters

21 January 2018

1 reference

Antiangiogenic effect of propranolol on the growth of the neuroblastoma xenografts in nude mice

21 January 2018

1 reference

Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment

21 January 2018

1 reference

β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma.

21 January 2018

1 reference

Do stress responses promote leukemia progression? An animal study suggesting a role for epinephrine and prostaglandin-E2 through reduced NK activity

21 January 2018

1 reference

Chronic stress enhances progression of acute lymphoblastic leukemia via β-adrenergic signaling.

21 January 2018

1 reference

Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis.

21 January 2018

1 reference

Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor

21 January 2018

1 reference

Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer

21 January 2018

1 reference

Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism

21 January 2018

1 reference

Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis

21 January 2018

1 reference

Prevention of pancreatic cancer by the beta-blocker propranolol

21 January 2018

1 reference

Effect of chronic restraint stress on human colorectal carcinoma growth in mice

21 January 2018

1 reference

[Could treatments with beta-blockers be associated with a reduction in cancer risk?]

21 January 2018

1 reference

Antihypertensive drug use and the risk of prostate cancer (Canada)

21 January 2018

1 reference

Effect of long-term propranolol treatment on hepatocellular carcinoma incidence in patients with HCV-associated cirrhosis.

21 January 2018

1 reference

Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort

21 January 2018

1 reference

Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials

21 January 2018

1 reference

Norepinephrine antagonists and cancer risk.

21 January 2018

1 reference

A cohort study of antihypertensive medication use and breast cancer among Danish women.

21 January 2018

1 reference

Beta blocker use and colorectal cancer risk: population-based case-control study

21 January 2018

1 reference

Does β-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study.

21 January 2018

1 reference

Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer

21 January 2018

1 reference

Therapeutic effect of β-blockers in triple-negative breast cancer postmenopausal women.

21 January 2018

1 reference

Beta blockers and breast cancer mortality: a population- based study

21 January 2018

1 reference

Use of β-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study

21 January 2018

1 reference

Beta-blocker usage and breast cancer survival: a nested case-control study within a UK clinical practice research datalink cohort.

21 January 2018

1 reference

β-Blocker use and all-cause mortality of melanoma patients: results from a population-based Dutch cohort study.

21 January 2018

1 reference

β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study

21 January 2018

1 reference

Effect of β-blockers and other antihypertensive drugs on the risk of melanoma recurrence and death.

21 January 2018

1 reference

Impact of beta blockers on epithelial ovarian cancer survival

21 January 2018

1 reference

Use of ß-blockers and mortality following ovarian cancer diagnosis: a population-based cohort study.

21 January 2018

1 reference

Impact of beta blocker medication in patients with platinum sensitive recurrent ovarian cancer-a combined analysis of 2 prospective multicenter trials by the AGO Study Group, NCIC-CTG and EORTC-GCG.

21 January 2018

1 reference

Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy

21 January 2018

1 reference

Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy

21 January 2018

1 reference

Exposure to ACEI/ARB and β-Blockers Is Associated with Improved Survival and Decreased Tumor Progression and Hospitalizations in Patients with Advanced Colon Cancer

21 January 2018

1 reference

Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment

21 January 2018

1 reference

Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon

21 January 2018

1 reference

Meta-analysis of the effects of beta blocker on survival time in cancer patients

21 January 2018

1 reference

The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors

21 January 2018

1 reference

Cardiovascular drug class specificity: beta-blockers

21 January 2018

1 reference

Possible association of beta2- and beta3-adrenergic receptor gene polymorphisms with susceptibility to breast cancer

21 January 2018

1 reference

Autonomic nerve development contributes to prostate cancer progression

21 January 2018

1 reference

An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer

21 January 2018

1 reference

Role of endothelial nitric oxide synthase (eNOS) in chronic stress-promoted tumour growth

21 January 2018

1 reference

Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies

21 January 2018

1 reference

Role of eNOS in neovascularization: NO for endothelial progenitor cells

21 January 2018

1 reference

Tumour maintenance is mediated by eNOS.

21 January 2018

1 reference

The role of tumour-derived iNOS in tumour progression and angiogenesis

21 January 2018

1 reference

Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy

21 January 2018

1 reference

Inducible nitric oxide synthase expression and its prognostic significance in colorectal cancer.

21 January 2018

1 reference

Functional involvement of β3-adrenergic receptors in melanoma growth and vascularization.

21 January 2018

1 reference

The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis

21 January 2018

1 reference

S-nitrosylation of Bcl-2 inhibits its ubiquitin-proteasomal degradation - a novel antiapoptotic mechanism that suppresses apoptosis

21 January 2018

1 reference

Catecholamines augment collateral vessel growth and angiogenesis in hindlimb ischemia

21 January 2018

1 reference

Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system

21 January 2018

1 reference

Catecholamines act via a beta-adrenergic receptor to maintain fetal heart rate and survival

21 January 2018

1 reference

Noradrenaline is essential for mouse fetal development

21 January 2018

1 reference

Role of nitric oxide in placental vascular development and function

21 January 2018

1 reference

Activation of nitric oxide synthase by beta 2-adrenoceptors in human umbilical vein endothelium in vitro

21 January 2018

1 reference

Functional, biochemical and molecular biological evidence for a possible beta(3)-adrenoceptor in human near-term myometrium

21 January 2018

1 reference

Is the beta3-adrenoceptor (ADRB3) a potential target for uterorelaxant drugs?

21 January 2018

1 reference

Beta3-adrenoceptor is the predominant beta-adrenoceptor subtype in human myometrium and its expression is up-regulated in pregnancy

21 January 2018

1 reference

Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma.

21 January 2018

1 reference

Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials

21 January 2018

1 reference

Long-term use of antihypertensive drugs and risk of cancer

21 January 2018

1 reference

Stage-specific associations between beta blocker use and prognosis after colorectal cancer

21 January 2018

1 reference

Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells

21 January 2018

1 reference

Beta-blocker usage after malignant melanoma diagnosis and survival: a population-based nested case-control study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MED.21336

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523517%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference